Earnings Call · Q1 FY2024·2024-05-06

Q1 24EPS 0.00%·Rev n/aQ4 23EPS +6.67%·Rev n/aQ3 23EPS 0.00%·Rev n/aQ2 23EPS +27.78%·Rev n/a⚠ consensus missing

CRESCENT BIOPHARMA, INC. CBIO

Christian Dinneen-Long — Chief Financial Officer

Harout Semerjian — Chief Executive Officer

Edwin Rock — Chief Medical Officer

−3.1%1d on move date−3.2% vs SPY3d−6.3%5d−18.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CBIO calls or request research access.

More CBIO calls Browse calls Request research access